These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6446398)

  • 21. Influence of serum protein binding and mode of administration on penetration of five cephalosporins into subcutaneous tissue fluid in humans.
    Hoffstedt B; Walder M
    Antimicrob Agents Chemother; 1981 Dec; 20(6):783-6. PubMed ID: 7325644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salicylate pharmacokintics in the dog.
    McCann WP; Palmisano PA
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):17-25. PubMed ID: 4686099
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacokinetics and bioavailability of cefquinome in healthy piglets.
    Li XB; Wu WX; Su D; Wang ZJ; Jiang HY; Shen JZ
    J Vet Pharmacol Ther; 2008 Dec; 31(6):523-7. PubMed ID: 19000274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of chlorpheniramine maleate in man.
    Peets EA; Jackson M; Symchowicz S
    J Pharmacol Exp Ther; 1972 Feb; 180(2):364-74. PubMed ID: 5010678
    [No Abstract]   [Full Text] [Related]  

  • 25. [Aminophylline dosage from the standpoint of pharmacokinetics].
    Dudziński W
    Pol Tyg Lek; 1977 Oct; 32(44):1733-5. PubMed ID: 917922
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmacokinetics after discontinuous intravenous administration of azlocillin].
    Naber K; Adam D
    Arzneimittelforschung; 1983; 33(3):429-32. PubMed ID: 6683518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of chronic lobular hepatitis on pharmacokinetics of cefoperazone--a novel galactose single-point method as a measure of residual liver function.
    Hu OY; Tang HS; Chang CL
    Biopharm Drug Dispos; 1994 Oct; 15(7):563-76. PubMed ID: 7849232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on protein binding of antibiotics. II. Effect of apalcillin on protein binding and pharmacokinetics of cefoperazone and cefazolin.
    Watanabe Y; Hayashi T; Kitayama R; Yasuda T; Saikawa I; Shimizu K
    J Antibiot (Tokyo); 1981 Jun; 34(6):753-7. PubMed ID: 6456252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cefpiramide kinetics and plasma protein binding in cholestasis.
    Demontes-Mainard F; Vinçon G; Labat L; Amouretti M; Necciari J; Kieffer G; Bannwarth B
    Br J Clin Pharmacol; 1994 Mar; 37(3):295-7. PubMed ID: 8198940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of cefazolin in normal and uremic subjects.
    Welling PG; Craig WA; Gordon AL; Kunin CM
    Clin Pharmacol Ther; 1974 Apr; 15(4):344-53. PubMed ID: 4821438
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of the concentrations of ceftazidime in the serum of newborn infants after intravenous and intramuscular administration.
    Boccazzi A; Rizzo M; Caccamo ML; Assael BM
    Antimicrob Agents Chemother; 1983 Dec; 24(6):955-6. PubMed ID: 6362562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Some determinants of the distribution of penicillins and cephalosporins in the body. Practical and theoretical considerations.
    Barza M; Weinstein L
    Ann N Y Acad Sci; 1974 May; 235(0):613-20. PubMed ID: 4527978
    [No Abstract]   [Full Text] [Related]  

  • 33. Cefoperazone concentrations in human aqueous humor after intravenous administration.
    Axelrod JL; Kochman RS
    Am J Ophthalmol; 1982 Jul; 94(1):103-5. PubMed ID: 6211988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disulfiram-like reaction associated with a parenteral cephalosporin.
    Foster TS; Raehl CL; Wilson HD
    Am J Hosp Pharm; 1980 Jun; 37(6):858-9. PubMed ID: 6446854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Characteristics of drugs necessitating a continuous parenteral flow].
    Dixneuf B
    Anesth Analg (Paris); 1977; 34(6):1121-5. PubMed ID: 26295
    [No Abstract]   [Full Text] [Related]  

  • 37. Dose-independent pharmacokinetics of the cardioprotective agent dexrazoxane in dogs.
    Baldwin JR; Lewis RC; Phillips BA; Overmyer SK; Hatfield NZ; Narang PK
    Biopharm Drug Dispos; 1996 Aug; 17(6):541-50. PubMed ID: 8866044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetic study of a cephalosporin: cefoperazone in patients with a Kehr drain].
    Farquet C; Marti MC; Balant L; Cochet B; Rudhardt M; Fabre J; Rohner A
    Schweiz Med Wochenschr; 1982 Jan; 112(4):123-9. PubMed ID: 6461067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pharmacokinetic study of cefoperazone.
    Fujita K; Fujita HM
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):395-7. PubMed ID: 4044071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peritoneal absorption of cefoperazone in rats.
    Najjar TA
    J Chemother; 1992 Feb; 4(1):23-6. PubMed ID: 1403065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.